全文获取类型
收费全文 | 29295篇 |
免费 | 2192篇 |
国内免费 | 687篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 851篇 |
妇产科学 | 675篇 |
基础医学 | 2336篇 |
口腔科学 | 429篇 |
临床医学 | 3033篇 |
内科学 | 8521篇 |
皮肤病学 | 497篇 |
神经病学 | 1381篇 |
特种医学 | 530篇 |
外国民族医学 | 3篇 |
外科学 | 1083篇 |
综合类 | 4180篇 |
一般理论 | 1篇 |
预防医学 | 2061篇 |
眼科学 | 1122篇 |
药学 | 3498篇 |
10篇 | |
中国医学 | 1055篇 |
肿瘤学 | 803篇 |
出版年
2023年 | 345篇 |
2022年 | 364篇 |
2021年 | 814篇 |
2020年 | 866篇 |
2019年 | 832篇 |
2018年 | 833篇 |
2017年 | 901篇 |
2016年 | 931篇 |
2015年 | 938篇 |
2014年 | 1644篇 |
2013年 | 2300篇 |
2012年 | 1709篇 |
2011年 | 1853篇 |
2010年 | 1470篇 |
2009年 | 1422篇 |
2008年 | 1573篇 |
2007年 | 1500篇 |
2006年 | 1261篇 |
2005年 | 1078篇 |
2004年 | 1043篇 |
2003年 | 908篇 |
2002年 | 706篇 |
2001年 | 660篇 |
2000年 | 569篇 |
1999年 | 492篇 |
1998年 | 402篇 |
1997年 | 367篇 |
1996年 | 299篇 |
1995年 | 281篇 |
1994年 | 267篇 |
1993年 | 253篇 |
1992年 | 239篇 |
1991年 | 210篇 |
1990年 | 171篇 |
1989年 | 190篇 |
1988年 | 187篇 |
1987年 | 176篇 |
1986年 | 178篇 |
1985年 | 246篇 |
1984年 | 231篇 |
1983年 | 136篇 |
1982年 | 181篇 |
1981年 | 164篇 |
1980年 | 164篇 |
1979年 | 144篇 |
1978年 | 112篇 |
1977年 | 96篇 |
1976年 | 78篇 |
1975年 | 56篇 |
1973年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
王志敏 《中国工业医学杂志》2022,35(5):463-465
[摘要]?目的?探讨GeneXpert MTB/RIF检测技术在肺结核诊断中的应用价值。方法?以2020年7月—2021年6月在天门市第一人民医院治疗的疑似肺结核患者107例作为研究对象,所有患者均留取痰标本,进行痰涂片、痰培养、GeneXpert MTB/RIF检测、比例法药敏试验。以培养法和比例法药敏结果为金标准,计算GeneXpert MTB/RIF检测结核分枝杆菌(Mycobacterium tuberculosis,MTB)及其对于利福平耐药性检测的灵敏度、特异度、与金标准的的一致率。结果?107例疑似肺结核患者中,痰涂片阳性39例(36.45%),涂片阴性68例(63.55%)。以痰培养结果为金标准,GeneXpert MTB/RIF检测TBM的灵敏度为85.42%(41/48),特异度为88.14%(52/59)。GeneXpert MTB/RIF与痰培养诊断一致率为86.92%(93/107);进一步分析,GeneXpert MTB/RIF检测痰涂片阳性患者MTB的灵敏度为97.22%(35/36),特异度为33.33%(1/3),检测涂片阴性患者MTB的灵敏度为50.00%(6/12),特异度为91.07%(51/56)。以比例法药敏结果为金标准,确认痰培养阳性36例患者中利福平耐药有4例(11.11%),敏感的有32例(88.89%);GeneXpert MTB/RIF检测痰培养阳性患者利福平耐药的灵敏度为75.00%(3/4),特异度为93.75%(30/32)。GeneXpert MTB/RIF与比例法药敏试验一致率为91.67%。结论?GeneXpert MTB/RIF检测技术对于肺结核诊断以及利福平的耐药分析具有重要实用价值,可以作为金标准。 相似文献
4.
5.
6.
目的探讨乙肝相关性肝癌临床病理学特征与溶血磷脂酸(LPA)和高敏C反应蛋白(hs-CRP)表达的相关性。方法选取2019年1月至2020年1月间河南省驻马店市中心医院收治的198例乙肝相关性肝癌患者作为乙肝组,198例酒精相关性肝癌患者作为酒精组。两组患者都进行血清hs-CRP和LPA表达检测,调查患者的病理学特征并进行相关性分析。结果乙肝组患者血清hs-CRP和LPA含量均高于酒精组,差异均有统计学意义(均P <0.05)。两组患者血清ALP、AFP、ALT、AST和GGT含量比较,差异均无统计学意义(P> 0.05)。乙肝组不同临床分期和组织学分化患者的血清hs-CRP和LPA含量比较,差异均有统计学意义(均P <0.05)。乙肝组患者的临床分期和组织学分化与血清hs-CRP和LPA表达均存在相关性,差异均有统计学意义(均P <0.05)。患者的临床分期和组织学分化均为影响hs-CRP和LPA表达的重要因素,差异均有统计学意义(均P <0.05)。结论相对于酒精相关性肝癌,乙肝相关性肝癌的血清hs-CRP和LPA呈现高表达,与患者的临床病理学特征存在相关性。 相似文献
7.
Background:We aim to evaluate the efficiency of Raman spectroscopy (RS) in diagnosing suspected patients with intrahepatic cholangiocarcinoma (ICC), manifested by diagnostic sensitivity, specificity, and accuracy.Methods:We will research widely the articles concerning the use of RS in ICC through authenticated database including PubMed/Medline, EMBASE, Web of Science, Ovid, Web of Knowledge, Cochrane Library, and CNKI between January 2012 and November 2020, retrieving at least 1500 spectra with strict criteria. This study will be carried out in accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We are going to summarize the test performance using random effects models.Results:Based on the pooled sensitivity, specificity, and diagnostic accuracy, we intend to provide the relative diagnostic efficiency in ICC through RS.Conclusion:Through this systematic review and meta-analysis, we intend to provide the pooled sensitivity, specificity and diagnostic accuracy of RS in the diagnosis of suspected ICC. Other parameters like positive likelihood ratios (LR), negative LR, diagnostic odds ratio (DOR), and area under curve (AUC) of the summary receiver operating characteristics (SROC) curve will also be calculated and related figures will be drawn to help illustrate the efficacy of RS in the diagnosis of ICC. 相似文献
8.
The novel coronavirus disease (COVID-19), first detected in December of 2019 and declared a global pandemic in March of 2020, continues to pose a serious threat to public health and safety worldwide. Many individuals report anxiety in response to this threat, and at high levels, such anxiety can result in adverse mental health outcomes and maladaptive behavioral responses that have consequences for the health of communities more broadly. Predictors of excessive anxiety in response to COVID-19 are understudied. Accordingly, the present study examined psychological factors that predict more intense COVID-19-related anxiety. 438 community members completed measures assessing COVID-19-related anxiety as well as psychological variables hypothesized to predict anxious responding to the threat of COVID-19. As expected, obsessive-compulsive symptoms related to contamination, the fear of arousal-related body sensations (i.e., anxiety sensitivity), and body vigilance each predicted more severe anxiety related to the pandemic. Obsessive-compulsive symptoms related to responsibility for causing harm also emerged as a predictor. Study limitations and implications are discussed. 相似文献
9.
《Value in health》2022,25(7):1235-1252
ObjectivesThe incidence of type 1 diabetes mellitus is increasing every year requiring substantial expenditure on treatment and complications. A systematic review was conducted on the cost-effectiveness of insulin formulations, including ultralong-, long-, or intermediate-acting insulin, and their biosimilar insulin equivalents.MethodsMEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, HTA, and NHS EED were searched from inception to June 11, 2021. Cost-effectiveness and cost-utility analyses were included if insulin formulations in adults (≥ 16 years) with type 1 diabetes mellitus were evaluated. Two reviewers independently screened titles, abstracts, and full-text articles, extracted study data, and appraised their quality using the Drummond 10-item checklist. Costs were converted to 2020 US dollars adjusting for inflation and purchasing power parity across currencies.ResultsA total of 27 studies were included. Incremental cost-effectiveness ratios ranged widely across the studies. All pairwise comparisons (11 of 11, 100%) found that ultralong-acting insulin was cost-effective compared with other long-acting insulins, including a long-acting biosimilar. Most pairwise comparisons (24 of 27, 89%) concluded that long-acting insulin was cost-effective compared with intermediate-acting insulin. Few studies compared long-acting insulins with one another.ConclusionsLong-acting insulin may be cost-effective compared with intermediate-acting insulin. Future studies should directly compare biosimilar options and long-acting insulin options and evaluate the long-term consequences of ultralong-acting insulins. 相似文献
10.
Marc Evans MD Susanne Engberg MD Mads Faurby MSc João Diogo Da Rocha Fernandes MSc Pollyanna Hudson MSc William Polonsky PhD 《Diabetes, obesity & metabolism》2022,24(3):377-390
We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of adherence to and persistence with antidiabetic medication in adults with T2D, and associations with glycaemic control, microvascular and/or macrovascular complications, hospitalizations and healthcare costs. Ninety-two relevant studies were identified, the majority of which were retrospective and reported US data. The proportions of patients considered adherent (median [range] 51.2% [9.4%-84.3%]) or persistent (median [range] 47.7% [16.9%-94.0%]) varied widely across studies. Multiple studies reported an association between greater adherence/persistence and greater reductions in glycated haemoglobin levels. Better adherence/persistence was associated with fewer microvascular and/or macrovascular outcomes, although there was little consistency across studies in terms of which outcomes were improved. More adherent and more persistent patients were typically less likely to be hospitalized or to have emergency department visits/admissions and spent fewer days in hospital annually than less adherent/persistent patients. Greater adherence and persistence were generally associated with lower hospitalization costs, higher pharmacy costs and lower or budget-neutral total healthcare costs compared with lower adherence/persistence. In conclusion, better adherence and persistence in people with T2D is associated with lower rates of microvascular and/or macrovascular outcomes and inpatient hospitalization, and lower or budget-neutral total healthcare expenditure. Education and treatment strategies to address suboptimal adherence and persistence are needed to improve clinical and economic outcomes. 相似文献